https://www.selleckchem.com/pr....oducts/pim447-lgh447
We systematically introduced the prospect of the systematic injection of AAV as an approach for AAV-based gene therapy for GBM. The use of drug nanocarriers to encapsulate drugs for oral administration may become an important strategy in addressing the challenging oral absorption of some drugs. In this study-with the premise of controlling single variables-we prepared model nanoparticles with different particle sizes, surface charges, and surface hydrophobicity/hydrophilicity. The two key stages of intestinal nanoparticles (NPs) a
Like
Comment
Share
